Eleclazine hydrochloride is a novel inhibitor of late Na+ current (IC50: 0.7 uM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 185 | |
2 mg | In stock | $ 333 | |
4 mg | In stock | $ 502 | |
10 mg | In stock | $ 842 | |
20 mg | In stock | $ 1321 |
Description | Eleclazine hydrochloride is a novel inhibitor of late Na+ current (IC50: 0.7 uM). |
Targets&IC50 | Na+ current:0.7 uM |
In vitro | Inhibition by GS-6615 of ATX-II enhanced late INa is potently correlated with shortening of myocyte APD and isolated heart MAPD. Eleclazine hydrochloride inhibits ATX-II enhanced late INa in ventricular myocytes, shorten the ATX-II induced prolongation of APD, MAPD, QT interval. It also decreased spatiotemporal dispersion of repolarization and ventricular arrhythmias. Selective inhibition of cardiac late INa with eleclazine hydrochloride confers dual protection against vulnerability to ischemia-induced AF. That decreases atrial and ventricular repolarization abnormalities before and during adrenergic stimulation without negative inotropic effects. |
Synonyms | GS 6615 hydrochloride |
CAS No. | 1448754-43-5 |
Chemical Formula | C21H17ClF3N3O3 |
Molecular Weight | 451.83 |
Solubility | DMSO: 100 mg/mL (221.32 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom